Since arginine entry into the NOS and arginase pathways could have multiple effects, both positive and negative, on lung processes during pathological conditions (e.g. inflammation and fibrosis), we used CAT2-deficient mice to test the net effect of reducing transport of arginine in experimental asthma and experimental lung fibrosis. The gene discussed is SLC7A2; the disease is asthma.